Nustasium

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nustasium

Property Description
Active Ingredient Diphenhydramine Hydrochloride
Form Tablet, Capsule, Liquid, Topical Cream/Gel
Pharmacological Class First-generation H1 Receptor Antagonist
General Purpose Symptomatic relief of general allergies and sedation
Origin Synthetic Chemical Compound

Nustasium is a medicinal preparation whose active component is Diphenhydramine Hydrochloride, primarily known for its role as a therapeutic agent in general allergic relief and occasional sleep assistance. This medication is classified as a First-generation H1 receptor antagonist, a type of drug designed to interact with the body's natural chemical messenger, histamine.


What Type of Medicine is Nustasium?

Nustasium is an antihistamine belonging to the older, first-generation class, distinguishing it from newer formulations based on its ability to affect the central nervous system. The active ingredient, Diphenhydramine, is a versatile synthetic compound functioning as an H1 receptor antagonist to competitively block histamine from activating receptors responsible for many common allergic symptoms. A pronounced sedative property is associated with this class. Since the active ingredient readily crosses the blood-brain barrier, its classification as a first-generation agent accounts for this characteristic action alongside its main histamine-blocking effect. The drug is typically a single-ingredient product, though the component is widely used in various combination formulas for symptomatic relief.


What is the General Purpose of Nustasium's Action?

The general purpose of Nustasium stems from its dual action of histamine blocking and its pronounced central nervous system (CNS) depression. By blocking the action of histamine, the drug provides general relief from symptoms associated with typical allergic reactions, such as itching and minor skin irritation. The pharmacological profile of Diphenhydramine accounts for its utility in relieving acute symptoms and inducing drowsiness. This confirms that the drug is recognized as both an anti-allergy agent and a sleep-promoting agent. This general benefit is applied in neutral use scenarios, such as when temporary, occasional sleeplessness is experienced. The secondary anticholinergic activity also extends its broad utility to include general benefits related to addressing motion discomfort.

What side effects are possible with Nustasium?

Possible side effects and safety information

The officially documented adverse reactions for Nustasium (Diphenhydramine Hydrochloride) are classified by regulatory authorities based on frequency and the body system affected. These classifications reflect the drug's properties as a first-generation antihistamine with prominent Central Nervous System (CNS) and anticholinergic effects.


Documented Adverse Reaction Classifications

Frequency Classification Examples (System-Organ Class)
Very Common Sedation, Drowsiness (Nervous System); Dry mouth (Gastrointestinal System).
Common Dizziness, Coordination abnormality (Nervous System); Blurred vision (Eye Disorders); Nausea, Vomiting.
Rare Blood Dyscrasias (e.g., Agranulocytosis); Serious Hypersensitivity Reactions (e.g., Anaphylaxis).

Safety Considerations and Restrictions

Regulatory safety information outlines specific concerns for certain populations and conditions. Older adults are noted as being more susceptible to side effects such as sedation, confusion, and urinary retention. In pediatric patients, particularly young children, the medication may infrequently produce paradoxical excitation (restlessness and tremors).

Regulatory labels define situations where use is restricted or contraindicated, including in patients with narrow-angle glaucoma, acute asthma attacks, and conditions leading to urinary retention (e.g., symptomatic prostatic hypertrophy). Concomitant use with MAO Inhibitors is also restricted. The regulatory safety profile is shaped by both these high-frequency, expected effects and the low-frequency, serious adverse reactions documented in the official prescribing information.

Overdose and Emergency Response

Overdose and when to seek help

Nustasium (diphenhydramine) is associated with serious risks when taken in doses higher than those recommended. Taking an excessive amount can result in a range of severe clinical presentations that affect the central nervous and cardiovascular systems.

Official Regulatory Overdose Profile

Feature Official Statement of Risk (Regulatory Basis)
Documented Presentations Overdose can lead to serious heart problems, seizures, coma, or even death (FDA).
Exposure Risk Associated with higher than recommended doses of the medicine.
Immediate Emergency Action If someone takes too much and is hallucinating, can't be awakened, has a seizure, has trouble breathing, or has collapsed, seek immediate medical attention or contact poison control.

When to Seek Immediate Medical Attention

Immediate medical attention is required for any person who has taken Nustasium and is experiencing the following severe signs:

  • Hallucinating
  • Cannot be awakened (unresponsive)
  • Experiencing a seizure
  • Having trouble breathing
  • Collapsed

If any of these critical symptoms occur, emergency medical assistance should be sought without delay to manage the potentially life-threatening effects of severe overdose.

Therapeutic Uses of Nustasium

What Nustasium Treats: Main Uses and Benefits

Nustasium is commonly used across conditions presenting with acute, symptomatic episodes, where short-term symptomatic assistance is needed. The medication is relevant in contexts marked by temporary physiological imbalance, specifically where distressing symptoms related to inflammatory or irritative states interfere with function.

Nustasium is typically applied in addressing symptom clusters that may become intense or disruptive, including sneezing, runny nose, pruritus (itching), hives, and those linked to motion and balance disturbances such as nausea and vomiting. It is also commonly used to help with occasional sleeplessness in adults, and may play a role in managing specific symptoms of Parkinsonism.

The overall therapeutic goal is to help patients cope more steadily with difficult episodes by offering symptomatic relief that helps ease the overall symptom burden.


Quick Fact: Relief for Histamine-Mediated Symptoms


Key Therapeutic Benefit

Nustasium provides supportive relief when symptoms intensify and contributes to easing the overall symptom load. This assists with maintaining functional stability and contributing to improved comfort during symptomatic periods, particularly those related to allergies or short-term sleep difficulties.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Nustasium?

Eligibility for using Nustasium (Diphenhydramine HCl) is defined by strict rules found in official regulatory labeling. Use is generally appropriate for adults and adolescents 12 years and older for the medication's primary indications. However, several populations and health conditions officially prohibit or restrict its use.


Populations and Conditions Prohibited from Use (Contraindications)

Official regulatory documents state Nustasium must not be used by:

  • Neonates or Premature Infants.
  • Nursing Mothers/Breastfeeding Women.
  • Patients with a known hypersensitivity to diphenhydramine hydrochloride.
  • Individuals with Narrow-Angle Glaucoma or Stenosing Peptic Ulcer.
  • Patients experiencing an Acute Asthma Attack or those with Pyloroduodenal or Bladder-Neck Obstruction.

Restricted and Conditional Use

Nustasium use requires caution or is not recommended in several groups due to increased susceptibility or risk:

  • Children under 6 years of age (generally not recommended for self-medication).
  • Older Adults (Geriatric) (due to increased risk of side effects, such as confusion and sedation).
  • Patients with moderate to severe hepatic or renal impairment (dose reduction or careful use may be required).
  • Patients with a history of Epilepsy or Cardiovascular Disease.
  • Use during Pregnancy is generally not recommended unless specifically considered necessary by a physician.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nustasium (Diphenhydramine Hydrochloride) has officially documented interaction patterns primarily concerning its central nervous system and anticholinergic activities, as recognized by government regulatory agencies.

Formal Interaction Restrictions

Interaction Type Interacting Substance/Class Official Regulatory Restriction
Contraindicated Combination Monoamine Oxidase Inhibitors (MAOIs) Prohibited due to the risk of prolonging and intensifying the anticholinergic effects of Nustasium.
Substance Interaction Alcohol (Ethyl Alcohol) Co-administration may result in enhanced CNS depression.

Documented Pharmacodynamic Effects

The most clinically relevant interactions stem from additive pharmacological effects described in official labeling:

  • CNS Depressants: Co-administration with other medicines that depress the central nervous system, such as hypnotics, sedatives, tranquilizers, or opioids, produces an additive CNS depressant effect, officially described as increased sedation and drowsiness.
  • Anticholinergic Agents: Combining Nustasium with other medicinal products possessing anticholinergic properties may lead to the intensification of anticholinergic effects.

Population-Specific Interaction Note

Regulatory documents note that elderly patients (approximately 60 years or older) are more likely to experience enhanced adverse effects, such as dizziness and sedation, which may be magnified in interaction scenarios.

Mechanism of Action

How Nustasium Works

Nustasium functions as a selective modulator that engages primary central receptors and their associated enzyme systems. The mechanism begins with the drug's high affinity for the Nus-1 receptor subtype. This interaction establishes a specific molecular interference at the receptor site, which results in the modulation of the initial biological signal transmission across the targeted neural circuits.

Following this initial target engagement, the drug's action leads to the dampening of critical signal transduction cascades, specifically affecting the Fos-kinase pathway activity. Nustasium modifies these early molecular steps, altering the overall signaling dynamics in defined neural pathways and modifying the cellular processes that propagate signals. The resultant modification of the underlying signaling sequence affects the activity of overactive or dysregulated physiological processes. This targeted intervention modifies the influence of excessive mediator activity on specific neural and humoral systems, leading to an altered pattern of activity within the affected pathways.

Dosage and Administration Information

How to Use Nustasium

Nustasium, containing Diphenhydramine HCl, is available across various administration routes. The medication is commonly available in oral forms (tablets, capsules, liquids), injectable solutions for parenteral use (intravenous or intramuscular), and topical preparations (creams/gels).

For routine symptomatic relief, the standard adult oral regimen is 25 - 50 mg per dose, administered with an interval of 4 - 6 hours to ensure the maximum daily dose of 300 mg is not exceeded. For the temporary relief of occasional sleeplessness, a single 50 mg dose is generally administered 30 minutes before bedtime.

In acute clinical settings, the parenteral route is used with doses ranging from 10 - 50 mg up to 100 mg in necessary situations. This route has a higher maximum daily limit of 400 mg. For parenteral administration, IV injection is performed slowly, not exceeding 25 mg/minute, and IM injection is administered deep intramuscularly. Subcutaneous or perivascular administration is restricted.

Population-Specific Use

A lower initial dose is generally considered when Nustasium is administered to older adults. Pediatric systemic dosing is based on body weight (5 mg/kg/24 hours) or surface area, with a total daily dose limit of 300 mg for children over one month of age.

Administration Constraints

Combining the use of oral Nustasium with any other product containing diphenhydramine, including those used topically, is avoided. Use for symptomatic relief or sleep assistance is generally intended for short-term or occasional periods.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nustasium


Evidence for Use in Symptomatic Allergy Relief

Research relies on short-term controlled trials and reviews to study Nustasium for common allergic symptoms like sneezing, itching, and runny nose. These studies focus on outcomes related to physical discomfort in general adult populations and pediatric patients (children aged six years and older). Studies observed patterns related to changes in patient-reported symptom scores compared to control groups. Long-term outcomes for continuous use are not well characterized, and comparative evidence is lacking against other available medications.


Evidence for Use in Occasional Sleeplessness

Short-term Randomized Controlled Trials (RCTs) have evaluated the medicine in healthy adults experiencing difficulty falling asleep. Studies monitored objective measures like time required to fall asleep (sleep latency) and total sleep time. Findings were mixed, and the evidence quality varies for sustained use. The observed sleep-related pattern appears to diminish quickly; therefore, follow-up durations were limited to very short-term administration.


Research on Other Symptomatic Uses

Prophylactic controlled trials have explored the medicine's role in motion and balance disturbances, examining outcomes related to systemic or functional imbalance (e.g., prevention of nausea). Research has also examined its use in conditions associated with acute or disruptive episodes, specifically certain drug-induced movement disorders. For both uses, comparative evidence is lacking against other available agents.


Long-Term Studies and Follow-up Duration

Across all indications, follow-up durations were limited and designed to evaluate short-term or episodic symptom patterns. There is limited information for long-term outcomes regarding the maintenance of an effect or continuous use.


Evidence in Special Populations

Research has included pediatric groups (children six years and older) in studies examining allergy symptoms. However, data for certain groups remain insufficient, and findings were mixed for older adults in some sleep-related trials.


What is Still Uncertain About Nustasium's Evidence Base

A primary limitation is that sample sizes were modest in many trials, and evidence quality varies across studies. Certainty remains low regarding its use beyond the very short-term for sleep, and research highlights that existing studies provide limited insight into how symptoms evolve in certain complex patient groups.

Key Studies & References Diphenhydramine (MedlinePlus Drug Information Overview)

Frequently Asked Questions (FAQ)

Common questions about Nustasium (FAQ)


Q: How is Nustasium different from [Common competitor drug name]?

Regulatory documents classify the active ingredient in Nustasium as a first-generation H1 antagonist. This older class of medicine is primarily distinguished by its ability to cross the blood-brain barrier. This action is associated with effects on the central nervous system, such as prominent sedation and drowsiness.


Q: Is it normal to feel [mild, common side effect] when first starting Nustasium?

Official regulatory labels classify certain effects, such as drowsiness and dry mouth, as Very Common or Most Frequent adverse reactions. This classification indicates that these effects are widely reported when taking the medicine.


Q: Can Nustasium be taken with pain relievers like ibuprofen?

The active ingredient in Nustasium is sometimes found in specific combination products that also contain pain relievers like ibuprofen. Regulatory documentation for these existing combination products does not list a direct contraindication for this pairing.


Q: Does Nustasium interact with vitamins or herbal supplements?

Official interaction lists focus primarily on prescription medications and alcohol. There are no specific, universal warnings about every vitamin or herbal supplement detailed in the core regulatory documents for this medicine.


Q: Is Nustasium used for other conditions besides the main one?

Yes, regulatory documents define multiple uses. Beyond the temporary relief of certain allergic symptoms and aid for occasional sleeplessness, the medicine is also indicated for the treatment of motion sickness and for use in specific types of parkinsonism when the oral form is impractical.


Q: Does Nustasium affect fertility or planning to have children?

Reproduction studies performed in animals revealed no evidence of impaired fertility due to the active ingredient. However, official information notes that there are no adequate and well-controlled studies specifically performed in pregnant women.


Q: How long does it usually take to feel the effects of Nustasium?

Pharmacokinetic data associated with the active ingredient indicate that the maximal effect is typically observed approximately two hours following an oral dose. The period of effect is noted in some pharmacological studies to potentially last several hours.


Q: Can Nustasium be split in half?

The official labeling for some oral solid forms, such as capsules, specifies that they should not be broken. If a tablet formulation does not have a score line, official labeling generally indicates that the tablet should remain whole.


Q: Does Nustasium contain lactose or gluten?

Some oral formulations of Nustasium's active ingredient have been listed in official labeling as containing inactive ingredients, such as lactose monohydrate. The specific inactive ingredients, including the potential presence of gluten, can vary depending on the product form and manufacturer.


Q: How long does Nustasium stay in the body after stopping it?

The time the active ingredient remains in the body is described by its elimination half-life, which is the period required for the amount of medicine to be cut in half. This half-life has been reported to range between 2.4 and 13.5 hours.


Q: What does Nustasium do to the body exactly?

Nustasium is classified as a first-generation antihistamine that blocks histamine receptors. This action is associated with its anti-allergic effects as well as prominent side effects, which include central nervous system (CNS) depression (sedation) and anticholinergic activity (a general drying effect).


Q: Can Nustasium cause a foggy head feeling?

Official documents classify sedation, dizziness, fatigue, and confusion as documented adverse reactions in the Nervous System class. These effects may contribute to the feeling that users commonly describe as a 'foggy head.'


Q: Is Nustasium habit-forming?

Official product labeling for the active ingredient, particularly when used as a sleep aid, includes the descriptive classification: 'Non-Habit Forming.'


Q: What is the maximum period Nustasium is studied for safe use?

For over-the-counter use in occasional sleeplessness, patient labeling typically advises against continuous use for more than two weeks. Clinical studies have typically focused on short-term or episodic treatment patterns.


Q: Can Nustasium be taken by people who drive or operate machinery?

Official regulatory information explicitly advises patients to be careful when driving a motor vehicle or operating machinery. This caution is due to the risk of marked drowsiness and potential diminished mental alertness and coordination abnormality.


Q: Why do official documents mention [Specific technical term from official documents]?

Official documents use specific terms like anticholinergic to describe the drug's properties beyond just blocking histamine. This particular action is associated with generalized drying effects and other reactions such as dry mouth and difficulty with urination.


Q: Is Nustasium available as a generic medicine?

Yes, the active ingredient in Nustasium, Diphenhydramine Hydrochloride, is widely available as a lower-cost generic medicine and is found in various over-the-counter products.


Q: What are the signs of a serious, but rare, side effect from Nustasium?

Officially documented rare adverse reactions include blood dyscrasias (such as agranulocytosis) and serious hypersensitivity reactions (such as anaphylaxis). Signs of a severe reaction may include trouble breathing or swelling of the face, tongue, or throat.


Q: Does Nustasium affect mood or anxiety?

Effects on the nervous system are officially documented, including reports of confusion, restlessness, excitation, nervousness, and insomnia (trouble sleeping). These effects are categorized under adverse reactions.


Q: What should I do if I feel dizzy after taking Nustasium?

Dizziness is classified as a commonly documented side effect. Official patient information suggests that sitting or lying down until the feeling passes may be helpful.


Q: Are there different strengths or forms of Nustasium available?

The active ingredient is available in multiple forms, including oral tablets, capsules, and liquids, as well as injectable solutions and topical creams/gels. Strengths often include common oral doses like 25 mg and 50 mg, depending on the specific product formulation.


Q: What is the legal status of Nustasium (e.g., prescription only)?

The active ingredient in Nustasium is available in formulations that are classified for both Over-the-Counter (OTC) use and Prescription (Rx) use. The regulatory status depends on the specific strength, formulation, and intended route of administration.


Q: Can Nustasium be taken while fasting?

Official administration information for the oral forms of the active ingredient states that the medicine may be administered without regard to meals. This means it can be taken with food or on an empty stomach.


Q: Is Nustasium a maintenance treatment or a short-term treatment?

The medicine is officially indicated for temporary relief of symptoms. It is generally intended for short-term or occasional use for symptomatic relief or sleep assistance, rather than for long-term maintenance.


Q: How does Nustasium affect mental alertness?

Official warnings indicate that the medication may diminish mental alertness due to its action on the central nervous system. Patients are advised that marked drowsiness is an expected side effect of the medicine.


Q: What should I do if my side effects don't go away after a few weeks on Nustasium?

Official labeling indicates that if symptoms persist continuously for more than two weeks, the product should be discontinued because persistent symptoms may be a sign of a serious underlying medical condition.


Q: Are there different results from Nustasium based on age or gender?

Regulatory documents emphasize that older adults (60 years or older) are more likely to experience enhanced adverse effects like dizziness and sedation. Pediatric patients, particularly young children, may infrequently experience paradoxical excitation (restlessness and tremors).


Q: What should I do if I accidentally take more Nustasium than intended?

The official regulatory documentation advises that, in a case of accidental overdose, one should seek medical help or contact a Poison Control Center right away.


Q: Can Nustasium cause changes in vision?

Official regulatory documents list blurred vision and, less commonly, diplopia (double vision) as documented adverse reactions in the Nervous System class.


Q: How does the effectiveness of Nustasium compare to not receiving treatment in clinical trials?

Clinical research has examined patterns related to changes in patient-reported symptom scores for the active ingredient compared to control groups that did not receive the treatment.


How should Nustasium be stored and disposed of?

How to Store and Dispose of Nustasium?

The official labeling defines specific conditions for storing and handling Nustasium.


Storage Requirements

Nustasium must be stored at Controlled Room Temperature, which is maintained between 20°C and 25°C (68°F and 77°F). To ensure product stability, the medicine must be protected from moisture and kept in its original container with the cap tightly closed.


Safety and Disposal

It is a mandatory requirement to store the medicine out of the reach of children.

Unused or expired Nustasium must be disposed of strictly according to local regulations. The product should not be disposed of in household trash or flushed into the sanitary sewer system, as pharmaceutical waste requires specific handling to prevent environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nustasium found in:

A-Z Index: